Adjunct Topical Human Immunoglobulin IgG Therapy in Dry Eye Disease
Topical immunoglobulin IgG 0.4% as adjunct therapy seems to have a definitive role in reducing topical steroid and lubricant dependency in moderate to severe chronic DED compared to conventional therapy.
Authors
- Murugesan Vanathi (ORCID: https://orcid.org/0000-0002-3643-4260)
- Ashish Kumar Dubey (ORCID: https://orcid.org/0009-0008-3749-6755)
- Radhika Tandon (ORCID: https://orcid.org/0000-0001-9554-9933)
- Maroof Ahmad Khan (ORCID: https://orcid.org/0000-0001-9449-6518)
- Tulika Seth (ORCID: https://orcid.org/0000-0001-9760-7957)
- Thirumurthy Velpandian
- Noopur Gupta (ORCID: https://orcid.org/0000-0001-8022-6656)
- Sandeep Jain (ORCID: https://orcid.org/0000-0002-5815-370X)
- Manoranjan Mahapatra (ORCID: https://orcid.org/0009-0006-9223-0568)
- Livia Khan
Institutions
- New York Eye and Ear Infirmary (US)
- University of Illinois Chicago (US)
- Centre for Sight (IN)
- All India Institute of Medical Sciences (IN)
Publication Details
- Journal
- Indian Journal of Ophthalmology
- Published
- 2025-03-27
- DOI
- https://doi.org/10.4103/ijo.ijo_608_25
- Primary Topic
- Ocular Surface and Contact Lens
- Type
- article
- Field-Weighted Citation Impact
- 0.00